Tenaris SA (TS) Gets a Sell from Bank of America Securities
In a report released today, Joe Charuy from Bank of America Securities maintained a Sell rating on Tenaris SA (TS – Research Report). The ...
Insmed targets $405M-$425M ARIKAYCE revenue for 2025 while advancing brensocatib and TPIP programs
Key achievements included positive Phase 3 ASPEN data for brensocatib in bronchiectasis, record-breaking ARIKAYCE revenues, and advancements in other pipeline programs such as TPIP and ARIKAYCE's ...